Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Smoking cessation product labeling

This article was originally published in The Tan Sheet

Executive Summary

Smoking cessation product labeling: FDA's Drug Abuse Advisory Committee will consider the issue at its June 9 meeting in the Versailles Ballroom at the Holiday Inn Bethesda, 8120 Wisconsin Ave., Bethesda, Md. ("The Tan Sheet" April 21, p. 8). The meeting will start at 8:30 a.m. with a one-hour open public hearing and is scheduled to conclude at 5:30 p.m. On June 10, the committee will discuss clinical trial design to study therapies for cocaine addiction beginning at 8:30 a.m...





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts